Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €27.25 EUR
Change Today +0.127 / 0.47%
Volume 0.0
0I2 On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 2:19 PM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

ims health holdings inc (0I2) Snapshot

Open
€27.27
Previous Close
€27.12
Day High
€27.66
Day Low
€27.15
52 Week High
06/24/15 - €29.05
52 Week Low
07/9/14 - €18.36
Market Cap
9.2B
Average Volume 10 Days
1.1
EPS TTM
--
Shares Outstanding
338.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IMS HEALTH HOLDINGS INC (0I2)

ims health holdings inc (0I2) Related Businessweek News

View More BusinessWeek News

ims health holdings inc (0I2) Details

IMS Health Holdings, Inc. provides information and technology services to healthcare industry worldwide. Its principal products include national information offerings that provide performance metrics related to the sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity through multiple channels; and sub-national offerings, which offer information related to the measurement of sales at the regional, zip code, and individual prescriber level. The company also provides workflow analytics, a set of strategic, analytic, and support services for life sciences companies; and real-world evidence solutions, which integrate information from medical claims, prescriptions, electronic medical records, biomarkers, and government statistics that provide information about treatment patterns, disease progression, therapeutic switching, and concomitant diseases and treatments. In addition, the company offers a range of hosted and cloud-based applications, and associated implementation services; AnalyticsLink, software as a service based analytics solution; and MIDAS, which acts as a source of insight into international market dynamics. Further, it provides clinical solutions that help biopharmaceutical companies and clinical research organizations to design, plan, execute, and track clinical trials, as well as it integrates client data with company’s information and proprietary analytics that enable risk-sharing and pay-for-performance programs, network design and management, and population health management for payers and providers. The company primarily serves life science companies, including pharmaceutical, biotechnology, consumer health, and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers, and financial communities. IMS Health Holdings, Inc. was founded in 1954 and is based in Danbury, Connecticut.

10,200 Employees
Last Reported Date: 02/13/15
Founded in 1954

ims health holdings inc (0I2) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $1.6M
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $457.5K
Senior Vice President of Global Services
Total Annual Compensation: $426.3K
Senior Vice President of Strategy & Global Pr...
Total Annual Compensation: $410.0K
Senior Vice President of Information Offering...
Total Annual Compensation: $402.0K
Compensation as of Fiscal Year 2014.

ims health holdings inc (0I2) Key Developments

IMS Health and Foundation Medicine Announce Collaboration to Optimize Targeting of Precision Therapies in Oncology

IMS Health and Foundation Medicine, Inc. announced a collaboration to advance the understanding and effectiveness of precision medicines for treating cancer. Commercial, medical and outcomes research teams in biopharma and life sciences companies will now be able to leverage an offering that combines IMS Health’s powerful Real-World Evidence platform providing clinical and cost-of-care insights with Foundation Medicine’s dynamic knowledgebase of comprehensive cancer genomic profiles, all at the patient-anonymous level. Through the collaboration, IMS Health’s clients will gain unprecedented insights to rapidly assess health outcomes and effectiveness, and to improve cancer care by better connecting patients to the right targeted therapies at the right time. These enhanced oncologic insights will be powered by Evidence 360 and FoundationCORE. Evidence 360 is IMS Health’s scalable and secure RWE platform that helps clients extract, analyze and visualize real-world data to better understand and measure healthcare outcomes. It brings together IMS Health’s vast library of patient-anonymous data with other patient-anonymous sources of health information to help life sciences companies interpret real-world outcomes and better target their commercial efforts. FoundationCORE is a molecular information knowledgebase containing comprehensive cancer genomic information and insights from more than 43,000 clinical cases profiled by Foundation Medicine. FoundationCORE evolves in real-time, informed by every new cancer patient tested with the company’s commercial assays, FoundationOne and FoundationOne Heme.

IMS Health Plans Acquisitions

IMS Health Holdings, Inc. (NYSE:IMS) intends to make acquisitions. Ron Bruehlman, Senior Vice President and Chief Financial Officer of the company said: “Historically, we've spent about $100 million per year on tuck-in acquisitions, and then done an occasional larger acquisition, Cegedim being one, and if you go back a couple of years, SDI being the other. Frankly, we would love to have more of the Cegedim sorts of acquisitions. They are great. So super acquisitions, but they are few and far between and they are hard to come by. So we continue investing in acquisitions going forward, but absent a big one, that's not going to use all our cash.”

IMS Health Holdings, Inc. Presents at William Blair’s 35th Annual Growth Stock Conference, Jun-09-2015 11:30 AM

IMS Health Holdings, Inc. Presents at William Blair’s 35th Annual Growth Stock Conference, Jun-09-2015 11:30 AM. Venue: Four Seasons Hotel, Chicago, Illinois, United States. Speakers: Ronald E. Bruehlman, Chief Financial Officer and Senior Vice President.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
0I2:GR €27.25 EUR +0.127

0I2 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Informatica Corp $48.44 USD +0.005
Quintiles Transnational Holdings Inc $72.86 USD +0.24
Teradata Corp $35.91 USD +0.29
TransUnion $24.59 USD -0.18
Verisk Analytics Inc $73.42 USD -0.34
View Industry Companies
 

Industry Analysis

0I2

Industry Average

Valuation 0I2 Industry Range
Price/Earnings 77.0x
Price/Sales 3.9x
Price/Book 5.7x
Price/Cash Flow 18.4x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMS HEALTH HOLDINGS INC, please visit www.imshealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.